Clinical trials
Alzheimer s Disease clinical trials
Below are recruiting alzheimer s disease clinical trials, each written for real people, not researchers. We’re tracking 601 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04524338Recruiting
At-home brain stimulation study for dementia
This study looks at using a home device that delivers a mild electrical current to the brain (“tDCS”) over time in people with Alzheimer’s disease or other dementias. It aims to learn whether this approach is safe and potentially helpful for symptoms.
Montreal, QuebecAges 50–100 - NCT06561906Recruiting
Early Alzheimer's detection using scans, genetics and blood
This study uses brain scans, blood tests, and genetic information to find early signs of Alzheimer's disease before memory problems start. It aims to predict who might develop Alzheimer's in the future.
Nanjing, JiangsuAges 50–79 - NCT03946930Recruiting
Study of memory decline in Alzheimer’s disease
This trial studies people diagnosed with Alzheimer’s disease who are at a moderate stage of decline. It likely involves cognitive (memory/thinking) testing and care-partner input to help track changes over time.
Hong KongAges 65–92 - NCT07762092Recruiting
Registry of lecanemab treatment for Alzheimer's in Canada
This study collects information from people in Canada who have Alzheimer's disease and are prescribed the drug lecanemab (LEQEMBI). It helps doctors learn more about the drug's safety and effects in real-world use.
Calgary, AlbertaAges Any age - NCT07763392Recruiting
Normal cognitive test scores for adults
This study is testing a voice-controlled digital platform to measure normal memory and thinking abilities in healthy adults. By participating, you would help create a baseline of normal scores that doctors can use to compare against when assessing people with thinking problems.
Carlsbad, CaliforniaAges 18–100 - NCT05800028Recruiting
Study brain scans and social life in memory changes
This study looks at how memory and brain function relate to social interactions. It focuses on people with probable Alzheimer’s disease or a specific language-related condition, and on healthy partners matched by age and social background.
CaenAges 18–85 - NCT06608589Recruiting
Improving care transitions for older adults with memory problems
This study tests a program called CoMPAS+ MNCD to help older adults with memory or thinking problems move smoothly between care settings. It also looks at how to train healthcare workers and improve services in the region.
Québec, QuebecAges 65 years+ - NCT07602582RecruitingPhase 3
Donanemab Extension Study for Alzheimer's Disease
This is a follow-up study for people who already completed a previous donanemab trial (AACM). Donanemab is a medication designed to slow cognitive decline in early Alzheimer's disease by targeting amyloid buildup in the brain.
Phoenix, ArizonaAges 55 years+ - NCT07602283Recruiting
Music to Help with Pain and Memory Problems
This study tests whether listening to music can help reduce pain and improve thinking in people with early memory loss or mild dementia. Researchers will monitor brain activity, heart rate, and pain levels while you or your loved one participate in music sessions.
New Haven, ConnecticutAges 50–80 - NCT06730438Recruiting
Sound wave brain treatment for early dementia
This study tests whether a treatment called Transcranial Pulse Stimulation (using targeted sound waves) can help people with early-stage dementia. It aims to find a new way to improve brain function without surgery or drugs.
L’Aquila, ItalyAges 18 years+ - NCT07558785Enrolling by invitation
Testing speech and memory checks at home for early thinking problems
This study uses a video-based system at home to check your speech and memory, helping doctors spot thinking problems early using artificial intelligence. The goal is to see if this simple, at-home test can reliably catch early memory and thinking changes.
PilsenAges 40 years+ - NCT07496918RecruitingPhase 2
Brain effects of light and sound stimulation at 40 Hz
This study tests whether special lights and sounds (at a specific 'gamma' frequency) can safely affect brain activity. It is an early trial looking at how the brain responds to these gentle sensory stimulations.
Cambridge, MassachusettsAges 18–100 - NCT07465783Recruiting
Music therapy for sleep and calm in dementia care
This study tests whether a music therapist working one-on-one with people who have dementia can help them fall asleep better and stay calmer during the day. It takes place in a locked dementia care unit.
Saint-EtienneAges 60 years+ - NCT07425106Enrolling by invitation
Comparing a low-cost eye scanner for Alzheimer's research
This study uses a special, low-cost eye scanner to look at the back of the eye (retina) in people with early Alzheimer's or mild memory problems. It aims to find changes that might help with early detection.
Durham, North CarolinaAges 18–85 - NCT07413406Recruiting
Comparing two learning methods for dementia caregivers over 50
This study compares two ways of helping dementia caregivers learn caregiving skills: practicing memory recall versus reading materials. It aims to find which method works better to reduce stress for unpaid caregivers aged 50 or older.
Virginia Beach, VirginiaAges 50 years+ - NCT07413744RecruitingPhase 1
Gut health and probiotics study for memory concerns
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
Madison, WisconsinAges 60 years+ - NCT07392723RecruitingPhase 2
Flaxseed nutrition to protect memory in APOE4 adults
This study tests a special flaxseed-based nutrition drink to see if it can slow memory loss in older adults who have the APOE4 gene and mild cognitive impairment (early memory trouble). If you qualify, you'll take the drink daily for a year and have memory tests and brain scans.
New Brunswick, New JerseyAges 60 years+ - NCT07353502Recruiting
Early Alzheimer's brain connection study
This study looks at a specific brain pathway that may be linked to early memory loss in Alzheimer's disease. It compares people with early Alzheimer's to healthy older adults to understand how connections between brain cells start to break down.
Yiwu, ZhejiangAges 50 years+ - NCT06855368Recruiting
Biomarkers for tracking dementia progression
This study looks at biological markers to monitor how dementia changes over time. It may help understand the disease better in people with early Alzheimer's or mild cognitive impairment.
RomaAges 18 years+ - NCT07323914RecruitingPhase 3
Pain management for people with Alzheimer's and chronic pain
This study tests if opioid pain medicine is safe and effective for people with Alzheimer's disease who also have chronic pain. It aims to find better ways to manage pain in dementia.
BeijingAges 50–90 - NCT07309107Recruiting
Deep learning study of amyloid pet scans for memory issues
This trial is testing a deep learning tool on amyloid PET scans from patients with memory problems. It aims to improve diagnosis and understanding of Alzheimer's disease.
Vandœuvre-lès-NancyAges 18–99 - NCT07287852Enrolling by invitationPhase 2
Ginkgo biloba extract for mild cognitive impairment
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
JerusalemAges 65 years+ - NCT07290387Recruiting
Tele-Savvy support program for Latino caregivers
This study offers a program called Tele-Savvy for Latino caregivers to help you care for a loved one with Alzheimer's or a related dementia. You'll learn caregiving tips and get support, all from home using your own device.
Rochester, New YorkAges 18 years+ - NCT07238049Enrolling by invitation
Real-world dementia outcomes: an observational study
This study follows people with memory or thinking problems over time to learn more about how these conditions progress. It's an observational study, meaning no new treatments are tested—just information is collected from your regular care.
BangorAges 45 years+
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer s disease?
- Yes. Clin2 currently lists 601 recruiting alzheimer s disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer s disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer s disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.